由于美国耶鲁大学通过研究发现,长期服用含有苯丙醇胺(即“PPA”)的药物,有可能会引发出血性中风。因此,药监局在2000年11月15日,发出了《关于暂停销售和使用含“PPA”药品制剂的紧急通知》。在《通知》所列出的国内15种含“PPA”成分的药品中,中美史克公司的“康泰克”和“康得”不幸被列在首位和第2位。 As the United States Yale University study found that long-term use of drugs containing phenylpropanolamine (ie “PPA ”), may cause hemorrhagic stroke. Therefore, on November 15, 2000, the Food and Drug Administration issued the “Emergency Notice on the Suspension of the Use and Sale of PPA” Pharmaceutical Preparations. Among the 15 “PPA” -containing medicines listed in the “Notice,” “Contac” and “康 得” from Sino-US Schneider Electric Co. were unfortunately ranked first and second place .